TrialClinical journal of the American Society of Nephrology : CJASN2012
Eculizumab for dense deposit disease and C3 glomerulonephritis.
Andrew S Bomback et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
176 papers cite itlatest 60 shown
this papertrialcites it